About Lyceumworld
Lyceumworld is a Healthcare company based in India. It supplies reliable pharmaceutical products for epilepsy, stroke, and pain management. It operates on a B2B model. The company has 166 employees. Its Indian entity Lyceum Life Sciences Private Limited reported revenue of ₹42.37 Cr. Lyceumworld offers products and services including Epilepsy Medicines, Stroke Medicines, Pain Relief Drugs, GERD Treatments, and Antibiotics. Its focus areas include Pharmaceuticals, General Medicines, Antibiotics and Specialty Medicines.
Company details
Lyceum Life Sciences is a pharmaceutical company focused on delivering quality and affordable medicines for conditions like epilepsy, stroke, pain, GERD, antibiotics, and antioxidants. Based in Ahmedabad, India, they procure products from premium manufacturers and ensure compliance with international standards. They serve doctors, patients, and business associates through reliable distribution and marketing efforts, emphasizing patient-centered healthcare solutions.
- Headquarters India
- Employees 166
- SectorsHealthcare
- Email••••••••
- Website lyceumworld.com
- Social LinkedIn X Facebook Instagram
- Legal Name Lyceum Life Sciences Private Limited
- Date of Incorporation 21 Jun, 2019
- Jurisdiction Sanand, Gujarat, India
- Annual Revenue₹42.37 Cr
FY 2024 · +66% YoY
- Net Profit₹1.92 Cr
FY 2024 · 5% margin
- EBITDA₹3.16 Cr
FY 2024 · 7% margin
- Employee Count166
Associated legal entities of Lyceumworld
Lyceumworld operates through Lyceum Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Lyceum Life Sciences Private Limited CIN U24304GJ2019PTC108793 | Active | 21 Jun 2019 | Sanand, Gujarat | ₹42.4 Cr | 166 | 4 | View details |
Products & Services of Lyceumworld
Lyceumworld offers a comprehensive portfolio of products and services, including Epilepsy Medicines, Stroke Medicines, Pain Relief Drugs, GERD Treatments, and Antibiotics.
Treatments for managing epilepsy and related neurological conditions
Medications for stroke prevention and recovery support
Products for effective pain management and relief
Solutions for gastroesophageal reflux disease symptoms
Antibacterial agents for treating various infections
Board of directors of Lyceum Life Sciences Private Limited (Lyceumworld)
Lyceum Life Sciences Private Limited is the primary company behind Lyceumworld. The board of Lyceum Life Sciences Private Limited currently have 4 directors; the longest-serving is Laltu Adhikari, appointed in 2019. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Laltu Adhikari DIN 08490348 | Director | 21 Jun 2019 | 7 yrs 4 mo | Lyceum Life Sciences Private Limited |
| Mrinal Kanti Ghosh DIN 08586835 | Director | 16 Oct 2019 | 7 yrs | Lyceum Life Sciences Private Limited |
| Sanjay Maitra DIN 08893003 | Whole-time director | 21 Sep 2020 | 6 yrs 1 mo | Lyceum Life Sciences Private Limited |
| Sukanya Maitra DIN 11193278 | Director | 01 Jul 2025 | 1 yr 4 mo | Lyceum Life Sciences Private Limited |
Financials of Lyceumworld
Figures of Lyceum Life Sciences Private Limited, the primary company behind Lyceumworld, for FY 2024. Revenue was ₹42.37 Cr (+66% year on year). Net profit was ₹1.92 Cr (5% margin). EBITDA was ₹3.16 Cr (7% margin). Revenue has grown at a compounded annual rate of +114% over three years.
- ₹42.37 CrRevenue · FY 2024 · +66% YoY
- ₹1.92 CrNet profit · 5% margin
- ₹3.16 CrEBITDA · 7% margin
- ₹2.00 CrPaid-up capital
- 166Employees (provident fund records)
- +114%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Lyceum Life Sciences Private Limited are on its company page.
Detailed financial statements for Lyceumworld
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Lyceumworld
The website of Lyceumworld (lyceumworld.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▲ 12.8% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lyceumworld
Lyceumworld is headquartered in India.
Lyceumworld has 166 employees.
The primary company behind Lyceumworld, Lyceum Life Sciences Private Limited, reported revenue of ₹42.37 Cr for FY 2024, up 66% year on year.
Lyceum Life Sciences is a pharmaceutical company focused on delivering quality and affordable medicines for conditions like epilepsy, stroke, pain, GERD, antibiotics, and antioxidants. Based in Ahmedabad, India, they procure products from premium manufacturers and ensure compliance with international standards. They serve doctors, patients, and business associates through reliable distribution and marketing efforts, emphasizing patient-centered healthcare solutions.
Lyceumworld offers Epilepsy Medicines, Stroke Medicines, Pain Relief Drugs, GERD Treatments, and Antibiotics.
Lyceumworld operates through Lyceum Life Sciences Private Limited.
The legal entities of Lyceumworld currently have 4 directors, including Sanjay Maitra, Mrinal Kanti Ghosh, Laltu Adhikari and others.